Growth Metrics

Armata Pharmaceuticals (ARMP) Depreciation & Amortization (CF) (2016 - 2026)

Quarterly results put Depreciation & Amortization (CF) at $457000.0 for Q1 2026, up 21.22% from a year ago — trailing twelve months through Mar 2026 was $1.6 million (up 17.26% YoY), and the annual figure for FY2025 was $1.5 million, up 15.55%.

Armata Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 14 years, most recently at $457000.0 for Q1 2026.

  • Depreciation & Amortization (CF) reached $457000.0 in Q1 2026 per ARMP's latest filing, up from $431000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $457000.0 in Q1 2026 and bottomed at $200000.0 in Q2 2022.
  • Median Depreciation & Amortization (CF) over the past 5 years was $313000.0 (2024), compared with a mean of $304058.8.
  • The largest annual shift saw Depreciation & Amortization (CF) plummeted 33.33% in 2022 before it soared 41.63% in 2024.
  • Over 5 years, Depreciation & Amortization (CF) stood at $245000.0 in 2022, then rose by 19.59% to $293000.0 in 2023, then increased by 29.69% to $380000.0 in 2024, then rose by 13.42% to $431000.0 in 2025, then grew by 6.03% to $457000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for ARMP at $457000.0 in Q1 2026, $431000.0 in Q4 2025, and $370000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 1,395.22
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - -
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 55.90 Mn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 123.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 13.55 Mn
10 Armata Pharmaceuticals 301.92 Mn 297.17 Mn - 457,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 457,000.00
Mar 31, 2026 457,000.00
Dec 31, 2025 431,000.00
Dec 31, 2025 431,000.00
Sep 30, 2025 370,000.00
Sep 30, 2025 370,000.00
Jun 30, 2025 366,000.00
Jun 30, 2025 366,000.00
Mar 31, 2025 377,000.00
Mar 31, 2025 377,000.00
Dec 31, 2024 380,000.00
Dec 31, 2024 380,000.00
Sep 30, 2024 313,000.00
Sep 30, 2024 313,000.00
Jun 30, 2024 315,000.00
Jun 30, 2024 315,000.00
Mar 31, 2024 317,000.00
Mar 31, 2024 317,000.00
Dec 31, 2023 293,000.00
Dec 31, 2023 293,000.00
Sep 30, 2023 221,000.00
Sep 30, 2023 221,000.00
Jun 30, 2023 228,000.00
Jun 30, 2023 228,000.00
Mar 31, 2023 230,000.00
Mar 31, 2023 230,000.00
Dec 31, 2022 245,000.00
Dec 31, 2022 245,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 226,000.00
Mar 31, 2022 226,000.00
Dec 31, 2021 308,000.00
Dec 31, 2021 308,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Jun 30, 2021 300,000.00
Mar 31, 2021 281,000.00
Mar 31, 2021 281,000.00
Dec 31, 2020 274,000.00
Dec 31, 2020 274,000.00
Sep 30, 2020 300,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 300,000.00
Jun 30, 2020 300,000.00
Mar 31, 2020 295,000.00
Mar 31, 2020 295,000.00
Dec 31, 2019 302,000.00
Dec 31, 2019 302,000.00
Sep 30, 2019 400,000.00
Sep 30, 2019 400,000.00
Jun 30, 2019 335,000.00
Jun 30, 2019 335,000.00
Mar 31, 2019 348,000.00
Mar 31, 2019 348,000.00
Dec 31, 2018 212,000.00
Dec 31, 2018 212,000.00
Sep 30, 2018 336,000.00
Sep 30, 2018 336,000.00
Jun 30, 2018 401,000.00
Jun 30, 2018 401,000.00
Mar 31, 2018 89,000.00
Mar 31, 2018 89,000.00
Dec 31, 2017 88,000.00
Dec 31, 2017 88,000.00
Sep 30, 2017 85,000.00
Sep 30, 2017 85,000.00
Jun 30, 2017 85,000.00
Jun 30, 2017 85,000.00
Mar 31, 2017 85,000.00
Mar 31, 2017 85,000.00
Dec 31, 2016 93,000.00
Dec 31, 2016 93,000.00
Sep 30, 2016 87,000.00
Sep 30, 2016 87,000.00
Jun 30, 2016 85,000.00
Jun 30, 2016 85,000.00